Spiro Spireas, Ph.D.Chairman and Chief Executive Officer
Dr. Spiro Spireas is the Chairman of the Board and Chief Executive Officer of Sigmapharm Laboratories, which he founded on March 1, 2005.
His leadership, strategic vision, extensive academic and industrial background, technical experience, scientific knowledge and regulatory expertise, along with his innovative and problem-solving skills, are invaluable company assets. Spiro is the inventor and author of more than 80 international and domestic patents and 200 scientific papers, books, and other publications and presentations in the fields of pharmaceutics, pharmaceutical technology, pharmacokinetics and analytical chemistry. He is the company’s chief formulator leading our Unique Product Selection process and closely advising and supervising our formulation scientists. Spiro is also the inventor of several newly developed proprietary drug delivery systems currently used by the company that are either patented or actually remaining trade secrets by design. Dr. Spireas holds a Ph.D. degree in Pharmaceutics and an M.S. degree in Industrial Pharmacy, both from St. John's University, Jamaica, New York. He also holds a B.S. degree in Pharmacy from the Hellenic National University, Athens, Greece. Prior to forming Sigmapharm Laboratories, Spiro served as the Vice President of Research and Development for URL Pharma, Inc. (formerly URL/Mutual), Philadelphia, PA, where he developed various unique generic products including Felodipine extended release (ER) tablets, which remained for more than four years the only marketed generic equivalent to Astra-Zeneca's Plendil® ER tablets. Prior to joining the industry, Dr. Spireas served as a Professor of Pharmacy at the Arnold & Marie Schwartz College of Pharmacy of Long Island University, Brooklyn, New York, where he received his tenure as an Associate Professor, taught several graduate and undergraduate courses, consulted for the pharmaceutical and nutritional industries and conducted extensive research producing more than 20 Ph.D. and M.S. thesis dissertations.
Basil Theofanopoulos, Ph.D.Sr. Vice President, Research & Development
Dr. Basil Theofanopoulos is the Senior Vice President of the Research and Development Division of Sigmapharm Laboratories, where he is in charge of the company’s pharmaceutical sciences, product development, technical services and regulatory functions.
His more than 20 years of experience in the pharmaceutical industry in several leadership and management positions and his extensive scientific, regulatory, business development and technical expertise in the fields of pharmacology, pharmaceutics and pharmacokinetics, are invaluable company assets. As the head of Research & Development, he oversees the division’s Pharmaceutics, Product Development, Technical Services and Regulatory Affairs departments, and he also participates in our Unique Product Selection process. Basil has been an old academic collaborator of Dr. Spireas during and after their tenure as graduate students and doctoral candidates at St. John’s University, when they worked together and published several scientific articles and abstracts in the fields of pharmaceutical and analytical development. Prior to joining Sigmapharm in 2014, Dr. Theofanopoulos was the Managing Director of Gerolymatos, Inc., where he established and managed that company’s U.S. pharmaceutical activities, while previously also holding positions in that company as Scientific Advisor and Director of Pharmaceutical Business Development. Basil holds a Ph.D. degree in Pharmacology and a B.S. degree in Pharmacy, both from St. John’s University, Jamaica, New York.
Lokanath LenkaSr. Vice President, Analytical Chemistry
Mr. Lokanath Lenka is the Senior Vice President of the Analytical Chemistry Division of Sigmapharm Laboratories, where he is in charge of the company’s analytical development and testing, physicochemical evaluation, and quality control functions.
His more than 20 years of experience in analytical chemistry, business development, technology transfer and laboratory management, along with his extensive scientific, regulatory, compliance and technical expertise, are invaluable company assets. As the head of Analytical Chemistry, he oversees the division’s Analytical Development, Documentation Support and Quality Control departments, and he also participates in our Unique Product Selection process. Since 2014, he constantly collaborates with Dr. Spireas in certain scientific, analytical, manufacturing and regulatory organizational matters to reform and refine several company structures and systems. Prior to joining Sigmapharm in 2008 as the Director of Analytical Chemistry, Mr. Lenka served for 8 years at the Perrigo Company in positions of increasing responsibility, most recently holding the position of Supervisor of Analytical Research and Development at that company. He also worked for 2 years at each Caraco Pharmaceutical Laboratories and Ranbaxy, Inc. Mr. Lenka holds an M.Tech. degree in Analytical Chemistry from the Indian Institute of Technology (IIT), New Delhi, India. He also holds M.S. and B.S. degrees in Chemistry.
McKee MooreSr. Vice President, Sales & Marketing
McKee Moore is the Senior Vice President of the Sales & Marketing Department of Sigmapharm Laboratories, where he is in charge of the company’s product sale strategies, contract negotiations and customer relations functions.
His more than 30 years of experience and expertise in pharmaceutical sales and marketing, including his tremendous knowledge and creativity in the field of generic pharmaceutical sales, marketing and contract negotiations, are invaluable company assets. As the head of the company’s Sales & Marketing, Kee is responsible for achieving sales goals and initiatives while maximizing customer relationships. He constantly collaborates with Dr. Spireas and pertinent division-heads to improve existing, and develop new, marketing strategies related to our domestic and international business, increase and forecast the sales of our current product lines and effectively promote our new product launches. Prior to joining Sigmapharm in 2013, Mr. Moore served as the Vice President of Sales for Rising Pharmaceuticals, Vice President of National Accounts at Stada Pharmaceuticals, Vice President of Sales for Andrx Pharmaceuticals, Director of Sales for Teva Pharmaceuticals, Vice President of Sales for Biocraft Laboratories and Regional Sales Manager for Geneva Generics.
Peter K. Moutis, Esq.General Counsel
Mr. Peter Moutis is the General Counsel and Head of the Legal Affairs Department of Sigmapharm Laboratories, where he is in charge of all legal matters of the company, including but not limited to Paragraph-IV and commercial litigations, contractual matters and strategic negotiations.
His extensive experience and expertise in complex, domestic and international, transactional and litigation matters, strategic approach and problem-solving skills, along with his long close collaboration and coordination with Dr. Spireas, are invaluable company assets. Peter has been legal counsel for Dr. Spireas prior to the formation, and during the evolution, of Sigmapharm Laboratories from a start-up to a full-fledged, vertically integrated specialty pharmaceutical company. Prior to joining Sigmapharm in 2007, Mr. Moutis represented corporate entities in complex, domestic and international, transactional and litigation matters. Prior to entering a legal career, he worked in Washington, DC, as an Economist for the Federal Government in the regulatory field. Peter holds a J.D. degree from the Widener University School of Law, Chester, PA, where he received the Lindsay Law Award for significant achievement in legal research and writing. He also holds an M.A. degree in Economics from Georgetown University, Washington, DC, where he specialized in International Financial Markets and Industrial Organization, and a B.S. degree in Business Administration from Widener University, Chester, PA. Since 1985, Peter is a member of the New Jersey and Pennsylvania Bars.
Prakash PatelVice President, Quality Operations
Mr. Prakash Patel is the Vice President of the Quality Operations Division of Sigmapharm Laboratories, where he is in charge of the company’s commercial manufacturing, quality assurance and compliance functions.
His expertise and pivotal role in vertically integrating and efficiently managing the company’s day-to-day commercial operations are invaluable company assets. As the head of Quality Operations, he oversees the division’s Operations, Quality Assurance and Compliance & Auditing departments. Mr. Patel has participated in, and managed, several successful FDA inspections of the company and other key projects involving the construction, procurement, qualification and implementation of modern quality systems, manufacturing suites and equipment. Prakash is an example of the company’s recognition and promotion of its own in-house-grown talent. He joined Sigmapharm in 2011 as an Associate of our Quality Assurance department and, after distinguishing himself in several projects, he became the head of that department in 2014. Since mid-2018, he is in charge of a whole company-division encompassing three departments. Mr. Patel holds an M.S. degree in Pharmaceutical Manufacturing Engineering from the Stevens Institute of Technology, Hoboken, New Jersey, and a B.S. degree in Pharmacy from the Rajiv Gandhi University of Health Sciences, Bengaluru, India.
Richard A. KremerVice President, Administration & Finance
Mr. Richard Kremer is the Vice President of the Administration & Finance Division of Sigmapharm Laboratories, where he is in charge of the company’s finance, human resources and information technology functions.
His 40 years of experience and expertise in finance operations, manufacturing economics and administrative organization are invaluable company assets. As the head of Administration & Finance, he oversees the division’s Finance, Human Resources and Information Technology departments. Rick constantly collaborates with Dr. Spireas and company division or department heads to improve existing, and develop new, finance systems and structures, along with increasingly effective administrative tools. Coupled with 10 years of service at a division of Litton Industries, Mr. Kremer’s 28 years at URL Pharma, Inc. (formerly URL/Mutual) allow him to bring almost 40 years of experience in a manufacturing environment to Sigmapharm. His experience at URL Pharma span a period of annual sales growth from under $25M to more than $500M and cover all aspects of accounting, finance and payroll. Mr. Kremer managed all bank relations throughout this exponential growth period at that company as well as multiple changes in ownership. Mr. Kremer holds a B.S. degree in Accounting from the Pennsylvania State University, State College, PA, and is a member of the Pennsylvania Institute of Certified Public Accountants (PICPA).
Nikolaos SpiliotisDirector, Logistics & Facilities
Mr. Nikolaos (Nick) Spiliotis is the Head of the Logistics & Facilities Division of Sigmapharm Laboratories, where he is in charge of the company’s supply chain management, forecasting, planning, inventory, warehousing, engineering and construction functions.
His 30 years of experience in supply chain management, organizational skills and operational expertise are invaluable company assets. As the head of Logistics & Facilities, he oversees the division’s Logistics, Inventory & Warehousing and Engineering & Construction departments. Mr. Spiliotis is an example of the company’s recognition and promotion of its own in-house-grown talent. Nick joined Sigmapharm in 2013 as a Group Leader of our Logistics department and, after distinguishing himself in several projects, he became the head of that department in 2015. Since mid-2018, he is in charge of a whole company-division encompassing three departments. Before joining Sigmapharm, Mr. Spiliotis served in the Hellenic Navy as a finance and supply officer and retired with the rank of Captain. Nick holds an M.S. degree in Management and Logistics from the Florida Institute of Technology (FIT), Fort Lee, Virginia.